GlassScriptPhysician profile
Alexis Jones
NPI 1215999602
$3,525.46
in general payments reported to CMS, 2019-2025
24 companies · $24.15 in 2025
The $24.15 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2021: $185 · 2022: $685 · 2023: $2,363 · 2024: $163 · 2025: $24.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,350 · Food and Beverage: $1,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,350.31 |
| Food and Beverage | $1,199.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $1,686.73 | 2021-2024 | Acessa Provu System, Coolseal Generator, Aptima |
| Abbvie INC. | $453.49 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $272.13 | 2021-2023 | |
| Aspira Women'S Health INC | $165.85 | 2022 | |
| Myriad Women'S Health, INC. | $98.42 | 2023 | |
| Organon LLC | $87.08 | 2022-2024 | |
| Novo Nordisk INC | $78.09 | 2019-2024 | |
| Pfizer INC. | $73.42 | 2019-2023 | |
| Exeltis, USA INC. | $67.78 | 2021-2024 | Slynd |
| Scynexis, INC. | $64.45 | 2022 | |
| Therapeuticsmd, INC. | $61.75 | 2019-2022 | |
| Axonics, INC. | $53.52 | 2023 | Bulkamid, Axonics |
| Shield Therapeutics INC | $53.47 | 2023-2024 | Accrufer |
| Astellas Pharma US INC | $47.16 | 2023 | Veozah |
| Coopersurgical, INC. | $39.97 | 2021-2023 | Advincula Delineator Uterine Manipulator |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $36.52 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $34.98 | 2022 | |
| Channel Medsystems, INC. | $32.83 | 2023 | |
| Agile Therapeutics, INC. | $24.89 | 2022 | |
| Boston Scientific Corporation | $24.15 | 2025 | Bulkamid |
| Hologic INC | $23.52 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.38 | 2019 | |
| Evofem Biosciences, INC. | $12.39 | 2022 | |
| Monaghan Medical Corporation | $11.49 | 2023 | Aerochamber |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexis Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.